Your browser doesn't support javascript.
loading
Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation.
Einarsdottir, Sigrun; Martner, Anna; Nicklasson, Malin; Wiktorin, Hanna Grauers; Arabpour, Mohammad; Törnell, Andreas; Vaht, Krista; Waldenström, Jesper; Ringlander, Johan; Bergström, Tomas; Brune, Mats; Hellstrand, Kristoffer; Ljungman, Per; Lagging, Martin.
Afiliación
  • Einarsdottir S; Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg.
  • Martner A; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Nicklasson M; Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg.
  • Wiktorin HG; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Arabpour M; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Törnell A; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Vaht K; Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg.
  • Waldenström J; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Ringlander J; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Bergström T; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
  • Brune M; Department of Hematology and Coagulation, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg.
  • Hellstrand K; TIMM Laboratory, Sahlgrenska Center for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg.
  • Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Huddinge and Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm.
  • Lagging M; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Microbiology, Gothenburg, Sweden; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg. martin.lagging@medfak.gu.se.
Haematologica ; 107(6): 1479-1482, 2022 06 01.
Article en En | MEDLINE | ID: mdl-35236057
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / COVID-19 Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / COVID-19 Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article